Colonoscopy and new technology experiences and perceptions
Research type
Research Study
Full title
Patient and endoscopists' experiences and perceptions of colonoscopy and new technologies in colonoscopy
IRAS ID
281674
Contact name
Anne Gowing
Contact email
Sponsor organisation
Leeds Teaching Hospitals NHS Trust
Duration of Study in the UK
0 years, 11 months, 28 days
Research summary
Bowel cancer is the 3rd most common cancer in males and females. Most bowel cancers develop from pre-cancerous polyps in the bowel. Colonoscopy can detect and remove these polyps, thereby reducing the risk of developing bowel cancer. However, colonoscopy is an invasive procedure with inherent risk, and can be both uncomfortable and embarrassing to undergo. The risks and numerous other barriers often mean colonoscopy, and cancer preventing polyp removal, is not performed.
We aim to start the first in-human feasibility clinical investigation of a robotic magnetic colonoscope in 2021. The new device aims to reduce the discomfort and risk associated with colonoscopy. As part of the patient and end user involvement aspect of the project we aim to perform a mixed methodology inductive type research project exploring experiences of colonoscopy for patient and endoscopists. We will explore the experiences of conventional colonoscopy, barriers to colonoscopy and also patient and endoscopists sentiments on new technologies in endoscopy.
The study will follow an exploratory mixed methodology format with two parallel work-streams for patients and endoscopists. Each work-stream will consisting of a focus groups (1-2 for each patients and endoscopists), followed by 20 endoscopist and 30 patient in-depth interviews, then an online questionnaire. Each stage will be thematically analysed to form the semi-structured questions for the next stage. The target population will be endoscopists who perform colonoscopy and people who have undergone, or refused to undergo, a colonoscopy. Focus groups will be performed in groups of 6-10 participants, and both interview and focus groups will be performed via video/teleconferencing.
The study periods is August 2020 to November 2021.
Note: the protocol includes a stage 4 for the clinical trial participants. That stage does not need assessing in this application and will be included in the clinical trial application.REC name
North East - York Research Ethics Committee
REC reference
21/NE/0017
Date of REC Opinion
6 Jan 2021
REC opinion
Favourable Opinion